PRIMARY STUDY
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes
Key Findings: Delta-9-THCV are CB1 receptor antagonists in the cerebellum and piriform cortical.
Type of Study: Laboratory Study
Study Result: Inconclusive
Study Location(s): United Kingdom
Year of Pub: 2019
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Receptors Studied: CB1
